ArticleJournal of psychiatric research2016

Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.

Stephen F Smagula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.